Literature DB >> 30157457

CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation.

Kamilla Steensig, Kevin K W Olesen, Troels Thim, Jens C Nielsen, Svend E Jensen, Lisette O Jensen, Steen D Kristensen, Hans Erik Bøtker, Gregory Y H Lip, Michael Maeng.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30157457     DOI: 10.1016/j.jacc.2018.08.1046

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  2018 Korean Guideline of Atrial Fibrillation Management.

Authors:  Boyoung Joung; Jung Myung Lee; Ki Hong Lee; Tae Hoon Kim; Eue Keun Choi; Woo Hyun Lim; Ki Woon Kang; Jaemin Shim; Hong Euy Lim; Junbeom Park; So Ryoung Lee; Young Soo Lee; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-12       Impact factor: 3.243

2.  Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation.

Authors:  Maya El-Hajj; Roula Ajrouche; Salam Zein; Samar Rachidi; Sanaa Awada; Amal Al-Hajje
Journal:  Pharm Pract (Granada)       Date:  2020-06-03

3.  Nomograms Based on the Advanced Lung Cancer Inflammation Index for the Prediction of Coronary Artery Disease and Calcification.

Authors:  Wenjun Fan; Ying Zhang; Yixiang Liu; Zhenjiang Ding; Yueqiao Si; Fei Shi; Jingyi Liu; Lixian Sun
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 4.  Leukocyte Telomere Length as a Molecular Biomarker of Coronary Heart Disease.

Authors:  Olga V Zimnitskaya; Marina M Petrova; Natalia V Lareva; Marina S Cherniaeva; Mustafa Al-Zamil; Anastasia E Ivanova; Natalia A Shnayder
Journal:  Genes (Basel)       Date:  2022-07-12       Impact factor: 4.141

5.  Association of lymphocyte-to-monocyte ratio with total coronary plaque burden in patients with coronary artery disease.

Authors:  Yueqiao Si; Jingyi Liu; Weichao Shan; Ying Zhang; Chao Han; Ruijuan Wang; Lixian Sun
Journal:  Coron Artery Dis       Date:  2020-11       Impact factor: 1.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.